-
1
-
-
0028129403
-
Lp(a) lipoprotein in cardiovascular disease
-
Dahlén GH: Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108: 111-126, 1994
-
(1994)
Atherosclerosis
, vol.108
, pp. 111-126
-
-
Dahlén, G.H.1
-
2
-
-
0028025332
-
Lipoprotein(a): New insights into an atherogenic lipoprotein
-
Bartens W, Wanner C: Lipoprotein(a): New insights into an atherogenic lipoprotein. Clin Invest 72: 558-567, 1994
-
(1994)
Clin Invest
, vol.72
, pp. 558-567
-
-
Bartens, W.1
Wanner, C.2
-
3
-
-
0022546653
-
Lipoprotein(a) as a strong indicator for cerebrovasular disease
-
Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G: Lipoprotein(a) as a strong indicator for cerebrovasular disease. Stroke 17: 942-945, 1986
-
(1986)
Stroke
, vol.17
, pp. 942-945
-
-
Zenker, G.1
Koltringer, P.2
Bone, G.3
Niederkorn, K.4
Pfeiffer, K.5
Jurgens, G.6
-
4
-
-
0028167766
-
Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms
-
Farrer M, Game FL, Albers CJ, Neil HA, Winocour PH, Laker MF, Adams PC, Alberti KG: Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb 14: 1272-1283, 1994
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1272-1283
-
-
Farrer, M.1
Game, F.L.2
Albers, C.J.3
Neil, H.A.4
Winocour, P.H.5
Laker, M.F.6
Adams, P.C.7
Alberti, K.G.8
-
5
-
-
0028927460
-
Plasma concentration of lipoprotein(a) and the risk of future stroke
-
Ridker PM, Stampfer MJ, Hennekens CH: Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 273: 1269-1273, 1995
-
(1995)
JAMA
, vol.273
, pp. 1269-1273
-
-
Ridker, P.M.1
Stampfer, M.J.2
Hennekens, C.H.3
-
6
-
-
0027475415
-
Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)
-
Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, Konig P: Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 91: 397-401, 1993
-
(1993)
J Clin Invest
, vol.91
, pp. 397-401
-
-
Dieplinger, H.1
Lackner, C.2
Kronenberg, F.3
Sandholzer, C.4
Lhotta, K.5
Hoppichler, F.6
Graf, H.7
Konig, P.8
-
7
-
-
0026695108
-
Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients
-
Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86: 475-482, 1992
-
(1992)
Circulation
, vol.86
, pp. 475-482
-
-
Cressman, M.D.1
Heyka, R.J.2
Paganini, E.P.3
O'Neil, J.4
Skibinski, C.I.5
Hoff, H.F.6
-
8
-
-
0026951911
-
Increased lipoprotein(a) concentrations in chronic renal failure
-
Haffner SM, Gruber KK, Aldrete G Jr, Morales PA, Stern MP, Tuttle KR: Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol 3: 1156-1162, 1992
-
(1992)
J am Soc Nephrol
, vol.3
, pp. 1156-1162
-
-
Haffner, S.M.1
Gruber, K.K.2
Aldrete G., Jr.3
Morales, P.A.4
Stern, M.P.5
Tuttle, K.R.6
-
9
-
-
0027258777
-
Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis
-
Thillet J, Faucher C, Issad B, Allouache M, Chapman J, Jacobs C: Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis. Am J Kidney Dis 22: 226-232, 1993
-
(1993)
Am J Kidney Dis
, vol.22
, pp. 226-232
-
-
Thillet, J.1
Faucher, C.2
Issad, B.3
Allouache, M.4
Chapman, J.5
Jacobs, C.6
-
10
-
-
0027492029
-
Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome
-
Wanner C, Rader D, Bartens W, Kramer J, Brewer HB, Schollmeyer P, Wieland H: Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 119: 263-269, 1993
-
(1993)
Ann Intern Med
, vol.119
, pp. 263-269
-
-
Wanner, C.1
Rader, D.2
Bartens, W.3
Kramer, J.4
Brewer, H.B.5
Schollmeyer, P.6
Wieland, H.7
-
11
-
-
0026906318
-
Lipoprotein(a) levels in the nephrotic syndrome
-
Kanno H, Saito E, Fujioka T, Yasugi T: Lipoprotein(a) levels in the nephrotic syndrome. Intern Med 31: 1004-1008, 1992
-
(1992)
Intern Med
, vol.31
, pp. 1004-1008
-
-
Kanno, H.1
Saito, E.2
Fujioka, T.3
Yasugi, T.4
-
12
-
-
0027367807
-
Elevated lipoprotein(a) levels in primary nephrotic syndrome
-
Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J: Elevated lipoprotein(a) levels in primary nephrotic syndrome. Am J Kidney Dis 22: 808-813, 1993
-
(1993)
Am J Kidney Dis
, vol.22
, pp. 808-813
-
-
Faucher, C.1
Doucet, C.2
Baumelou, A.3
Chapman, J.4
Jacobs, C.5
Thillet, J.6
-
13
-
-
0027431356
-
Lipoprotein(a) in nephrotic syndrome
-
Stenvinkel P, Berglund L, Heimburger O, Pettersson E, Alvestrand A: Lipoprotein(a) in nephrotic syndrome. Kidney Int 44: 1116-1123, 1993
-
(1993)
Kidney int
, vol.44
, pp. 1116-1123
-
-
Stenvinkel, P.1
Berglund, L.2
Heimburger, O.3
Pettersson, E.4
Alvestrand, A.5
-
14
-
-
0029054501
-
Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: Relation to remission of proteinuria
-
Joven J, Simo JM, Vilella E, Camps J, Espinel E, Villabona C: Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: Relation to remission of proteinuria. Clin Chim 41: 908-913, 1995
-
(1995)
Clin Chim
, vol.41
, pp. 908-913
-
-
Joven, J.1
Simo, J.M.2
Vilella, E.3
Camps, J.4
Espinel, E.5
Villabona, C.6
-
15
-
-
85190705143
-
Serum Lp(a) in patients with nephrotic syndrome due to idiopathic membranous nephropathy
-
Siakotos M, Apostolou T, Papageorgakis N, Nikolopoulou N, Metaxatos G, Anagnostou M, Billis A: Serum Lp(a) in patients with nephrotic syndrome due to idiopathic membranous nephropathy [Abstract]. Nephrol Dial Transplant 8: 930, 1993
-
(1993)
Nephrol Dial Transplant
, vol.8
, pp. 930
-
-
Siakotos, M.1
Apostolou, T.2
Papageorgakis, N.3
Nikolopoulou, N.4
Metaxatos, G.5
Anagnostou, M.6
Billis, A.7
-
16
-
-
0024426378
-
Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin
-
Karadi I, Romics L, Palos G, Doman J, Kaszas I, Hesz A, Kostner GM: Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 35: 2121-2123, 1989
-
(1989)
Clin Chem
, vol.35
, pp. 2121-2123
-
-
Karadi, I.1
Romics, L.2
Palos, G.3
Doman, J.4
Kaszas, I.5
Hesz, A.6
Kostner, G.M.7
-
17
-
-
0021708959
-
Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome
-
Chan MK, Persaud JW, Varghese Z, Moorhead JF: Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome. Aunt N Z J Med 14: 841-847, 1984
-
(1984)
Aunt n Z J Med
, vol.14
, pp. 841-847
-
-
Chan, M.K.1
Persaud, J.W.2
Varghese, Z.3
Moorhead, J.F.4
-
18
-
-
0014897339
-
Lipoprotein lipase in clinical and experimental nephrosis
-
Yamada M, Matsuda I: Lipoprotein lipase in clinical and experimental nephrosis. Clin Chim Acta 30: 787-794, 1970
-
(1970)
Clin Chim Acta
, vol.30
, pp. 787-794
-
-
Yamada, M.1
Matsuda, I.2
-
19
-
-
0026717599
-
Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: Roles for low density lipoprotein receptors and heparan sulfate proteoglycans
-
Williams KJ, Fless GM, Petrie KA, Snyder ML, Brocia RW, Swenson TL: Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem 267: 13284-13292, 1992
-
(1992)
J Biol Chem
, vol.267
, pp. 13284-13292
-
-
Williams, K.J.1
Fless, G.M.2
Petrie, K.A.3
Snyder, M.L.4
Brocia, R.W.5
Swenson, T.L.6
-
20
-
-
0030666519
-
The atherogenic Lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor
-
McTigue Argraves K, Kozarsky KF, Fallon JT, Harpel PC, Strickland DK: The atherogenic Lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest 2170-2181, 1997
-
(1997)
J Clin Invest
, pp. 2170-2181
-
-
McTigue Argraves, K.1
Kozarsky, K.F.2
Fallon, J.T.3
Harpel, P.C.4
Strickland, D.K.5
-
21
-
-
0031979035
-
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis
-
de Sain-van der Velden MGM, Kaysen GA, Barrett HA, Stellaard F, Gadellaa MM, Voorbij HAM, Reijngoud DJ, Rabelink TJ: Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int 53: 994-1001, 1998
-
(1998)
Kidney int
, vol.53
, pp. 994-1001
-
-
De Sain-van Der Velden, M.1
Kaysen, G.A.2
Barrett, H.A.3
Stellaard, F.4
Gadellaa, M.M.5
Ham, V.6
Reijngoud, D.J.7
Rabelink, T.J.8
-
22
-
-
0031951669
-
Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes
-
de Sain-van der Velden MGM, Kaysen GA, de Meer K, Stellaard F, Voorbij HAM, Reijngoud DJ, Rabelink TJ, Koomans HA: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes. Kidney Int 53: 181-188, 1998
-
(1998)
Kidney int
, vol.53
, pp. 181-188
-
-
De Sain-van Der Velden, M.1
Kaysen, G.A.2
De Meer, K.3
Stellaard, F.4
Ham, V.5
Reijngoud, D.J.6
Rabelink, T.J.7
Koomans, H.A.8
-
23
-
-
0021062199
-
Isopropanol precipitation method for the determination of apolipoprotein B-specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B
-
Egusa G, Brady DW, Grundy SM, Howard BV: Isopropanol precipitation method for the determination of apolipoprotein B-specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res 24: 1261-1267, 1983
-
(1983)
J Lipid Res
, vol.24
, pp. 1261-1267
-
-
Egusa, G.1
Brady, D.W.2
Grundy, S.M.3
Howard, B.V.4
-
24
-
-
0013819609
-
Hydrolysis of proteins
-
Hill RL: Hydrolysis of proteins. Adv Protein Chem 20: 37-107, 1965
-
(1965)
Adv Protein Chem
, vol.20
, pp. 37-107
-
-
Hill, R.L.1
-
25
-
-
0025938419
-
Expressed hypervariable polymorphism of apolipoprotein (a)
-
Kamboh MI, Ferell RE, Kottke BA: Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 49: 1063-1074, 1991
-
(1991)
Am J Hum Genet
, vol.49
, pp. 1063-1074
-
-
Kamboh, M.I.1
Ferell, R.E.2
Kottke, B.A.3
-
26
-
-
0029985439
-
Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: Basis for a standardized isoform nomenclature
-
Marcovina SM, Hobbs HH, Albers JJ: Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: Basis for a standardized isoform nomenclature. Clin Chem 42: 436-439, 1996
-
(1996)
Clin Chem
, vol.42
, pp. 436-439
-
-
Marcovina, S.M.1
Hobbs, H.H.2
Albers, J.J.3
-
27
-
-
0028921349
-
Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a)
-
Ernst A, Helmhold M, Brunner C, Petho Schramm A, Armstrong VW, Muller HJ: Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem 270: 6227-6234, 1995
-
(1995)
J Biol Chem
, vol.270
, pp. 6227-6234
-
-
Ernst, A.1
Helmhold, M.2
Brunner, C.3
Petho Schramm, A.4
Armstrong, V.W.5
Muller, H.J.6
-
28
-
-
0025733654
-
Rapid derivatization and gas chromatographic determination of amino acids
-
Hušek P: Rapid derivatization and gas chromatographic determination of amino acids. J Chromatogr 552: 259-299, 1991
-
(1991)
J Chromatogr
, vol.552
, pp. 259-299
-
-
Hušek, P.1
-
29
-
-
0027131518
-
Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data
-
Foster DM, Barrett PH, Toffolo G, Beltz WF, Cobelli C: Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 34: 2193-2205, 1993
-
(1993)
J Lipid Res
, vol.34
, pp. 2193-2205
-
-
Foster, D.M.1
Barrett, P.H.2
Toffolo, G.3
Beltz, W.F.4
Cobelli, C.5
-
31
-
-
0001045879
-
Alterations in plasma Lp(a) lipoprotein and acute phase proteins after surgical operation [Abstract]
-
Kawade M, Maeda S, Abe A, Yamashiro M: Alterations in plasma Lp(a) lipoprotein and acute phase proteins after surgical operation [Abstract]. Clin Chem 30: 941, 1984
-
(1984)
Clin Chem
, vol.30
, pp. 941
-
-
Kawade, M.1
Maeda, S.2
Abe, A.3
Yamashiro, M.4
-
32
-
-
0023393811
-
Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma
-
Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C: Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 80: 458-465, 1987
-
(1987)
J Clin Invest
, vol.80
, pp. 458-465
-
-
Utermann, G.1
Menzel, H.J.2
Kraft, H.G.3
Duba, H.C.4
Seitz C, K.H.G.5
-
33
-
-
0006290666
-
Metabolism of apo(a) and apo B100 in human Lipoprotein(a)
-
Edited by Catapano AL, Gotto AM, Smith LC, Paoletti R, Amsterdam, the Netherlands, Kluwer and Fondazione Giovanni Lorenzini
-
Morrisett JM, Gaubatz JW, Nava MN, Guyton JR, Hoffman AS, Opekun AR, Hachey DL: Metabolism of apo(a) and apo B100 in human Lipoprotein(a). In: Drugs Affecting Lipid Metabolism, edited by Catapano AL, Gotto AM, Smith LC, Paoletti R, Amsterdam, The Netherlands, Kluwer and Fondazione Giovanni Lorenzini, 1993, pp 161-167
-
(1993)
Drugs Affecting Lipid Metabolism
, pp. 161-167
-
-
Morrisett, J.M.1
Gaubatz, J.W.2
Nava, M.N.3
Guyton, J.R.4
Hoffman, A.S.5
Opekun, A.R.6
Hachey, D.L.7
-
34
-
-
0027475419
-
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production
-
Rader DJ, Cain W, Zech LA, Usher D, Brewer HB: Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 91: 443-447, 1993
-
(1993)
J Clin Invest
, vol.91
, pp. 443-447
-
-
Rader, D.J.1
Cain, W.2
Zech, L.A.3
Usher, D.4
Brewer, H.B.5
-
35
-
-
0028245313
-
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
-
Rader DJ, Cain W, Ikewaki K, Talley G, Zech LA, Usher D, Brewer HB Jr: The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest 93: 2758-2763, 1994
-
(1994)
J Clin Invest
, vol.93
, pp. 2758-2763
-
-
Rader, D.J.1
Cain, W.2
Ikewaki, K.3
Talley, G.4
Zech, L.A.5
Brewer Hb Jr, U.D.6
-
36
-
-
0028069558
-
Lp(a) catabolism in hypercholesterolaemic individuals
-
Knight BL: Lp(a) catabolism in hypercholesterolaemic individuals. Chem Phys Lipids 67-68: 233-239, 1994
-
(1994)
Chem Phys Lipids
, vol.67-68
, pp. 233-239
-
-
Knight, B.L.1
-
37
-
-
0027477975
-
Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes
-
White AL, Rainwater DL, Lanford RE: Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res 34: 509-517, 1993
-
(1993)
J Lipid Res
, vol.34
, pp. 509-517
-
-
White, A.L.1
Rainwater, D.L.2
Lanford, R.E.3
-
38
-
-
0027962682
-
Apolipoprotein(a) is not associated with apolipoprotein B in human liver
-
Wilkinson J, Munro LH, Higgins JA: Apolipoprotein(a) is not associated with apolipoprotein B in human liver. J Lipid Res 35: 1896-1901, 1994
-
(1994)
J Lipid Res
, vol.35
, pp. 1896-1901
-
-
Wilkinson, J.1
Munro, L.H.2
Higgins, J.A.3
-
39
-
-
0026498273
-
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
-
Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE: Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem 267: 24369-24374, 1992
-
(1992)
J Biol Chem
, vol.267
, pp. 24369-24374
-
-
Chiesa, G.1
Hobbs, H.H.2
Koschinsky, M.L.3
Lawn, R.M.4
Hammer Re, M.S.D.5
-
40
-
-
0024524857
-
Production of lipoprotein(a) by primary baboon hepatocytes
-
Rainwater DL, Lanford RE: Production of lipoprotein(a) by primary baboon hepatocytes. Biochim Biophys Acta 1003: 30-35, 1989
-
(1989)
Biochim Biophys Acta
, vol.1003
, pp. 30-35
-
-
Rainwater, D.L.1
Lanford, R.E.2
-
41
-
-
0031041462
-
Expression of a recombinant apolipoprotein(a) in HepG2 cells: Evidence for intracellular assembly of lipoprotein(a)
-
Bonen DK, Hausman AML, Hadjiagapiou C, Skarosi SF, Davidson NO: Expression of a recombinant apolipoprotein(a) in HepG2 cells: Evidence for intracellular assembly of lipoprotein(a). J Biol Chem 272: 5659-5667, 1997
-
(1997)
J Biol Chem
, vol.272
, pp. 5659-5667
-
-
Bonen, D.K.1
Aml, H.2
Hadjiagapiou, C.3
Skarosi, S.F.4
Davidson, N.O.5
-
42
-
-
0026048441
-
Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis
-
Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH: Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 87: 2153-2161, 1991
-
(1991)
J Clin Invest
, vol.87
, pp. 2153-2161
-
-
Lackner, C.1
Boerwinkle, E.2
Leffert, C.C.3
Rahmig, T.4
Hobbs, H.H.5
-
43
-
-
0027331191
-
The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study
-
Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W: The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 13: 1558-1566, 1993
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 1558-1566
-
-
Brown, S.A.1
Morrisett, J.D.2
Boerwinkle, E.3
Hutchinson, R.4
Patsch, W.5
-
44
-
-
0025289843
-
Polymorphic forms of human apolipoprotein[a]: Inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]
-
Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W, Morrisett JD: Polymorphic forms of human apolipoprotein[a]: Inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res 31: 603-613, 1990
-
(1990)
J Lipid Res
, vol.31
, pp. 603-613
-
-
Gaubatz, J.W.1
Ghanem, K.I.2
Jr, G.J.3
Nava, M.L.4
Morrisett Jd, P.W.5
-
45
-
-
0026509691
-
Apolipoprotein (a) alleles determine lipoprotein (a) particle density and concentration in plasma
-
Kraft HG, Sandholzer C, Menzel HJ, Utermann G: Apolipoprotein (a) alleles determine lipoprotein (a) particle density and concentration in plasma. Arterioscler Thromb 12: 302-306, 1992
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 302-306
-
-
Kraft, H.G.1
Sandholzer, C.2
Menzel, H.J.3
Utermann, G.4
-
46
-
-
0024854850
-
Plasma Lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene
-
Gavish D, Azrolan N, Breslow JL: Plasma Lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. J Clin Invest 84: 2021-2027, 1989
-
(1989)
J Clin Invest
, vol.84
, pp. 2021-2027
-
-
Gavish, D.1
Azrolan, N.2
Breslow, J.L.3
-
47
-
-
0029038930
-
Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome
-
Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA: Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome. Am J Kidney Dis 26: 170-177, 1995
-
(1995)
Am J Kidney Dis
, vol.26
, pp. 170-177
-
-
Brown, C.D.1
Azrolan, N.2
Thomas, L.3
Roberts, K.G.4
Bostom, A.5
Zh, Z.6
Friedman, E.A.7
-
48
-
-
0031040724
-
Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome
-
Stenvinkel P, Berglund L, Ericsson S, Alvestrand A, Angelin B, Eriksson M: Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome. Eur J Clin Invest 27: 169-177, 1997
-
(1997)
Eur J Clin Invest
, vol.27
, pp. 169-177
-
-
Stenvinkel, P.1
Berglund, L.2
Ericsson, S.3
Alvestrand, A.4
Eriksson M, A.B.5
-
49
-
-
0028297882
-
Acute phase proteins and lipoprotein(a) in patients with severe hypercholesterolaemia and normal subjects
-
Crook MA, Haq S, Chusney G, Haq M, Tutt P: Acute phase proteins and lipoprotein(a) in patients with severe hypercholesterolaemia and normal subjects. Clin Chim Acta 224: 199-201, 1994
-
(1994)
Clin Chim Acta
, vol.224
, pp. 199-201
-
-
Ma, C.1
Haq, S.2
Chusney, G.3
Haq, M.4
Tutt, P.5
-
50
-
-
0029991296
-
Lipoprotein(a) in 505 hospitalized patients with various pathological states: Correlations with cardiovascular diseases and therapies
-
Constans J, Wendling G, Peuchant E, Camilleri G, Conri C: Lipoprotein(a) in 505 hospitalized patients with various pathological states: Correlations with cardiovascular diseases and therapies. Int Angiol 15: 1-5, 1996
-
(1996)
Int Angiol
, vol.15
, pp. 1-5
-
-
Constans, J.1
Wendling, G.2
Peuchant, E.3
Camilleri, G.4
Conri, C.5
-
51
-
-
0027716173
-
The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response
-
Ledue TB, Neveux LM, Palomaki GE, Ritchie RF, Craig WY: The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. Clin Chim Acta 223: 73-82, 1993
-
(1993)
Clin Chim Acta
, vol.223
, pp. 73-82
-
-
Ledue, T.B.1
Neveux, L.M.2
Palomaki, G.E.3
Ritchie, R.F.4
Craig, W.Y.5
-
52
-
-
0027163091
-
Localization of apolipoprotein(a) and B-100 in various renal diseases
-
Sato H, Suzuki S, Ueno M, Shimada H, Karasawa R, Nishi S, Arakawa M: Localization of apolipoprotein(a) and B-100 in various renal diseases. Kidney Int 43: 430-435, 1993
-
(1993)
Kidney int
, vol.43
, pp. 430-435
-
-
Sato, H.1
Suzuki, S.2
Ueno, M.3
Shimada, H.4
Karasawa, R.5
Arakawa M, N.S.6
-
53
-
-
0024289811
-
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor
-
Thiery J, Armstrong VW, Schleef J, Creutzfeldt C, Creutzfeldt W, Seidel D: Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr 66: 462-463, 1988
-
(1988)
Klin Wochenschr
, vol.66
, pp. 462-463
-
-
Thiery, J.1
Armstrong, V.W.2
Schleef, J.3
Creutzfeldt, C.4
Creutzfeldt, W.5
Seidel, D.6
-
54
-
-
0024437616
-
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels
-
Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL: HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 80: 1313-1319, 1989
-
(1989)
Circulation
, vol.80
, pp. 1313-1319
-
-
Kostner, G.M.1
Gavish, D.2
Leopold, B.3
Bolzano, K.4
Breslow Jl, W.M.S.5
-
55
-
-
0028205793
-
Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome
-
Wanner C, Bohler J, Eckardt HG, Wieland H, Schollmeyer P: Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome. Clin Nephrol 41: 138-143, 1994
-
(1994)
Clin Nephrol
, vol.41
, pp. 138-143
-
-
Wanner, C.1
Bohler, J.2
Eckardt, H.G.3
Wieland, H.4
Schollmeyer, P.5
-
56
-
-
0028212167
-
Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria
-
Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP: Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria. Nephrol Dial Transplant 9: 244-250, 1994
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 244-250
-
-
Gansevoort, R.T.1
Heeg, J.E.2
Dikkeschei, F.D.3
De Zeeuw, D.4
De Jong, P.E.5
Dullaart, R.P.6
-
57
-
-
0029839797
-
ACTH lowers serum lipids in steroid-treated hyperlipidemic patients with kidney disease
-
Berg AL, Nilsson-Ehle P: ACTH lowers serum lipids in steroid-treated hyperlipidemic patients with kidney disease. Kidney Int 50: 538-542, 1996
-
(1996)
Kidney int
, vol.50
, pp. 538-542
-
-
Berg, A.L.1
Nilsson-Ehle, P.2
|